Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP358182.RAApMjRjNYSf-yeVhA-y1OoChMulVVvKjEbuEGGP0nTMg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP358182.RAApMjRjNYSf-yeVhA-y1OoChMulVVvKjEbuEGGP0nTMg130_assertion type Assertion NP358182.RAApMjRjNYSf-yeVhA-y1OoChMulVVvKjEbuEGGP0nTMg130_head.
- NP358182.RAApMjRjNYSf-yeVhA-y1OoChMulVVvKjEbuEGGP0nTMg130_assertion description "[The GSTP1 Ile(105)Val polymorphism is associated in a dose-dependent fashion with increased survival of patients with advanced colorectal cancer receiving 5-FU/oxaliplatin chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP358182.RAApMjRjNYSf-yeVhA-y1OoChMulVVvKjEbuEGGP0nTMg130_provenance.
- NP358182.RAApMjRjNYSf-yeVhA-y1OoChMulVVvKjEbuEGGP0nTMg130_assertion evidence source_evidence_literature NP358182.RAApMjRjNYSf-yeVhA-y1OoChMulVVvKjEbuEGGP0nTMg130_provenance.
- NP358182.RAApMjRjNYSf-yeVhA-y1OoChMulVVvKjEbuEGGP0nTMg130_assertion SIO_000772 12072547 NP358182.RAApMjRjNYSf-yeVhA-y1OoChMulVVvKjEbuEGGP0nTMg130_provenance.
- NP358182.RAApMjRjNYSf-yeVhA-y1OoChMulVVvKjEbuEGGP0nTMg130_assertion wasDerivedFrom befree-2016 NP358182.RAApMjRjNYSf-yeVhA-y1OoChMulVVvKjEbuEGGP0nTMg130_provenance.
- NP358182.RAApMjRjNYSf-yeVhA-y1OoChMulVVvKjEbuEGGP0nTMg130_assertion wasGeneratedBy ECO_0000203 NP358182.RAApMjRjNYSf-yeVhA-y1OoChMulVVvKjEbuEGGP0nTMg130_provenance.